Articles

Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized controlled trial of the Rox Flow procedure for the treatment of resistant hypertension.

This is a roundup of some of the DAIC editor's choice of the most innovative new technologies showcased at ACC 2013, including products in the areas of interventional cardiology, patient...

Thoratec Corp. announced that it has successfully completed the first human use of HeartMate PHP (percutaneous heart pump). The first PHP patient was supported for over 60 minutes during a high-...

 

St. Jude Medical announced publication of results from its landmark RESPECT clinical trial in The New England Journal of Medicine.

 

Minimally invasive procedures significantly lower health payer costs and result in fewer missed workdays when compared to open surgery, according to a study published this week in the ...

Biotronik Iforia ICD/CRT-D CE-Approval

Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D...

March 25, 2013 — The largest randomized study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side effects...

Abbot MitraClip

Abbott announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted by majority (Yes: 5, No: 3) that the benefits...

ACC HRS Appropriate Use Criteria ICDs CRTs

The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty societies, released appropriate use criteria for implantable cardioverter-defibrillators (ICDs)...

Edwards Sapien, PARTNER, 3 year followup

The three-year results of a pivotal clinical study comparing the Edwards Sapien transcatheter heart valve and open-heart surgery demonstrated comparable outcomes. These new data from The PARTNER...